Lv3
330 积分 2022-11-14 加入
Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS
1天前
求助中
Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS
1天前
已关闭
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
1天前
已完结
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer
1天前
已完结
Therapiealgorithmus nach Versagen der Erstlinientherapie beim metastasierten Prostatakarzinom
3天前
已完结
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis
16天前
已完结
Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study
16天前
已完结
Outcomes Following Localized Prostate Cancer Treatment
16天前
已完结
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
16天前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
17天前
已完结
皖公网安备34019202002308
